Perimeter Medical Imaging Partners with Healthcare Innovators
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) has forged an important partnership with Intermountain Health, a leading nonprofit health system. This collaboration marks a significant milestone in medical technology, focusing on enhancing the treatment process for cancer patients. Specifically, they aim to investigate the clinical, social, and economic impacts of using Optical Coherence Tomography (OCT) coupled with artificial intelligence (AI) to minimize reoperations in cancer surgery.
Evaluating the Impact of Advanced Imaging Techniques
The partnership sets the stage for a series of studies designed to assess the value of Perimeter's proprietary OCT technology. The initial study will analyze reoperation rates and the associated healthcare costs for patients who have undergone breast-conserving surgery across selected hospital locations. This retrospective analysis aims to provide valuable insights into how advanced imaging can lead to cost-efficient healthcare solutions while improving patient outcomes.
Dr. Teresa Reading, medical director of breast surgery at Intermountain Health, expressed enthusiasm about integrating this innovative technology into clinical practice. She highlighted the potential of Perimeter's wide-field OCT for optimizing surgical oncology outcomes, ultimately facilitating better care delivery for cancer patients.
Transforming Surgical Outcomes and Healthcare Economics
Adrian Mendes, Perimeter's Chief Executive Officer, shared insights into the collaboration’s goals. Mendes emphasized that Intermountain Health's fully integrated healthcare system is uniquely equipped to evaluate the comprehensive costs of cancer reoperations, benefiting both patients and payers. This partnership aims to enhance Perimeter's market access strategies and support the FDA approval process for their next-generation, AI-enabled OCT system.
About Intermountain Health: A Leader in Healthcare Transformation
Intermountain Health has garnered recognition for its commitment to enhancing community health throughout its wide network, which includes 33 hospitals and around 400 clinics. The system is devoted to using evidence-based practices to ensure high-quality healthcare services are available at sustainable costs. Their integration of a health plans division enables them to reach a substantial member base, further amplifying their impact on patient care.
Empowering Cancer Care with Advanced Technology
Perimeter Medical Imaging AI is dedicated to revolutionizing cancer surgery through state-of-the-art imaging solutions. Their FDA-cleared Perimeter S-Series OCT system provides real-time insights by visualizing excised tissues on a cellular level, which is vital in surgical oncology. The ongoing development of their B-Series OCT system, combined with ImgAssist AI, represents a leap forward in AI technology, already showing promise in pivotal clinical trials.
This ongoing collaboration with Intermountain Health may establish a robust framework that not only improves surgical outcomes but also optimizes resource use and enhances patient care strategies. As both organizations move forward, they are excited about the possibilities that this joint venture could offer for patients facing cancer treatment.
Frequently Asked Questions
What is the purpose of Perimeter Medical Imaging's partnership with Intermountain Health?
The partnership aims to study the clinical, social, and economic benefits of advanced imaging technology in reducing cancer surgery reoperations.
What technology is being evaluated in the studies?
Perimeter's proprietary Optical Coherence Tomography (OCT) technology is at the center of these evaluations, particularly its application in breast-conserving surgeries.
Who is involved in this initiative?
Key figures include Dr. Teresa Reading from Intermountain Health and Adrian Mendes, the CEO of Perimeter Medical Imaging AI.
What is the significance of analyzing reoperation rates?
Understanding reoperation rates helps assess the effectiveness of surgical techniques and identify potential cost savings in healthcare.
What broader impact could this partnership have?
This collaboration could transform patient care by enhancing surgical outcomes and contributing to the growing body of evidence supporting innovative healthcare solutions.
